Company / R&D per Share
Cogent Biosciences, Inc. R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.09
FY2025
5-year range
$1.44 / $2.24
FY2021-FY2025
Trend
-6.6%
vs FY2024
Sector context
#98 of 207
Health Care
What the data says
At $2.09, Cogent Biosciences, Inc.'s r&d per share ranks #98 of 207 in the Health Care sector. R&D per Share has fluctuated over the past 9 years, ranging from $1.44 in FY2021 to $5.74 in FY2019.
Based on SEC 10-K filings.
2.09 in FY2025 with a 5-year CAGR of -2.1%.
Declined from $2.18 to $2.09 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- -2.1%
- 10-Year CAGR
- -
Sector benchmark
#98 of 207 in Health CareTop 47% of 207This company $2.09 Sector average $12.26
▼
-82.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 6.6% year-over-year.
- Ranks #98 out of 207 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.09 | -6.6% |
| FY2024 | $2.24 | +2.7% |
| FY2023 | $2.18 | +5.3% |
| FY2022 | $2.07 | +43.4% |
| FY2021 | $1.44 | -37.8% |
| FY2020 | $2.32 | -59.5% |
| FY2019 | $5.74 | +273.0% |
| FY2018 | $1.54 | -47.5% |
| FY2017 | $2.93 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026